• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Innovation Management >NUMBER OF R&D ALLIANCES AND INNOVATION OUTPUT: NONLINEAR RELATIONSHIP EVIDENCE FROM THE PHARMACEUTICAL INDUSTRY
【24h】

NUMBER OF R&D ALLIANCES AND INNOVATION OUTPUT: NONLINEAR RELATIONSHIP EVIDENCE FROM THE PHARMACEUTICAL INDUSTRY

机译：研发联盟和创新产出的数量：来自制药行业的非线性关系证据

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

What is the precise nature of the relationship between a firm's research and development alliance portfolio size and its innovation output? The existing literature is inconclusive between a positive linear relationship and a nonlinear variant. To address the issue, this study explores the relationship between alliance portfolio size and innovation output in the context of the pharmaceutical industry. Contrary to previous investigations, our results suggest increasing returns at a diminishing rate at a low to moderate alliance portfolio level while exhibiting increasingly higher returns at a moderate to high level of portfolio size. An advantage of the present investigation is that we draw from a larger data set of alliance agreements compared to earlier investigations. Additionally, the results provide improved reliability compared to previous studies where violations of some underlying assumptions have been overlooked. The paper concludes with a discussion of findings and suggestions for future research.
机译：公司的研发联盟投资组合规模与其创新产出之间的关系的确切性质是什么？现有文献在正线性关系和非线性变量之间没有定论。为了解决这个问题，本研究探讨了制药行业背景下联盟投资组合规模与创新产出之间的关系。与之前的研究相反，我们的结果表明，在低至中等规模的联盟投资组合水平下，收益率递减，而在中高规模的投资组合规模中则表现出越来越高的收益率。本调查的一个优势是，与早期调查相比，我们从更大的联盟协议数据集中获取信息。此外，与以前的研究相比，该研究结果提供了更高的可靠性，在以前的研究中，一些基本假设的违反被忽略了。本文最后讨论了发现和对未来研究的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号